je.st
news
Home
› IntelliCyt And FIMM Announce A Collaboration To Advance Personalized Medicine In Cancer Treatment
IntelliCyt And FIMM Announce A Collaboration To Advance Personalized Medicine In Cancer Treatment
2016-03-02 05:45:22| drugdiscoveryonline Home Page
IntelliCyt, a leading provider of integrated platforms that accelerate drug discovery, antibody screening and immuno-oncology research today announced a collaboration with the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki to further the development of personalized medicine in cancer treatment
Tags: treatment
medicine
advance
cancer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||